SNWV — SANUWAVE Health Cashflow Statement
0.000.00%
Last trade - 00:00- $243.46m
- $258.53m
- $32.63m
- 55
- 26
- 89
- 58
Annual cashflow statement for SANUWAVE Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -30.9 | -27.3 | -10.3 | -25.8 | -31.4 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 14.7 | 9.87 | -6.71 | 17.5 | 32.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.46 | 9.72 | -1.12 | 2.7 | 0.484 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -12.7 | -6.41 | -17.2 | -4.54 | 2.46 |
| Capital Expenditures | -0.053 | -0.529 | — | — | -0.49 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -20 | 0 | 0.332 | 0.021 | 0 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -20.1 | -0.529 | 0.332 | 0.021 | -0.49 |
| Financing Cash Flow Items | 0.022 | 1.74 | 0.695 | -0.639 | -1.49 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 33.4 | 5.12 | 17.4 | 5.21 | 6.35 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.677 | -1.82 | 0.534 | 0.644 | 8.44 |